{"id":520746,"date":"2021-07-30T08:48:06","date_gmt":"2021-07-30T12:48:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/"},"modified":"2021-07-30T08:48:06","modified_gmt":"2021-07-30T12:48:06","slug":"ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/","title":{"rendered":"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., July  30, 2021  (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its second quarter 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, August 6, 2021.<\/p>\n<p>Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details:<\/p>\n<ul type=\"disc\">\n<li>Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international)<\/li>\n<li>Conference ID: 6663619<\/li>\n<li>Webcast: Available in the <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/f9i37sez\" rel=\"nofollow noopener\" target=\"_blank\">\u201cInvestors\u201d section of the Ocugen website<\/a> and archived for approximately 45 days following the call<\/li>\n<\/ul>\n<p>\n        <strong>About\u202fOcugen, Inc.<\/strong><br \/>\n        <br \/>Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing\u202fa vaccine to\u202fsave lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat\u00a0multiple retinal diseases with one drug \u2013 \u201cone to many\u201d and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.\u202fWe are co-developing Bharat Biotech\u2019s COVAXIN\u2122 vaccine candidate for COVID-19 in the U.S.\u00a0and Canadian\u00a0markets.\u202fFor more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QUZuzmiQGJ4pT7_nphVhNkjbsAA2-dWAGeU2-qN5nnfHdxn7ddmk97QgcP6ZlRT_Eb7cdbNDGhuAlsPw9vVM0BUUwvOzJoPdoelW7dZOQp_yygcm1VJB0vsVLMpZKLXPrFRxpObThXQy1_s2nKn-V3gLuUb8lWDqWYYbWi9uCthf95jqAdWmut1BkjhhSqKPgnqlTf_DiFwCS60abfU7UUwP-rGVWrMn_EmVLxTgMZQ=\" rel=\"nofollow noopener\" target=\"_blank\">www.ocugen.com<\/a>.<\/p>\n<p><strong>Cautionary Note on Forward-Looking Statements <\/strong><br \/>This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. Such forward-looking statements within this press release include, without limitation, the intended use of net proceeds from the registered direct offering. We may, in some cases, use terms such as \u201cpredicts,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d \u201cproposed,\u201d \u201ccontinue,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from our current expectations, such as market and other conditions. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including the risk factors described in the section entitled \u201cRisk Factors\u201d in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events or otherwise, after the date of this press release.<\/p>\n<p>\n        <strong>Ocugen\u00a0Contact:<\/strong>\u00a0<br \/>Ken Inchausti<br \/>Head, Investor Relations &amp; Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Sll7_t87wJWAdxn-a0jCRhex_ux6CEvb3lZJ8pqHbVyvpkykKaJrf6-XEjo63zgAcffnRD9Ur2qwb_npOAawQQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>IR@Ocugen.com<\/u><\/a>\u00a0<\/p>\n<p>Please submit investor-related inquiries to:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4SI9C8XN47NxPYEbqLij6v1GeHw-8c3-3O3_nR1AKKx2QFNd1RHyYwwWWfFp_PxH0MeVehaSN5JdQeCErIRzMw==\" rel=\"nofollow noopener\" target=\"_blank\">IR@ocugen.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/a0113608-effb-4909-9935-381d4cb2a8c5\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., July 30, 2021 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its second quarter 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, August 6, 2021. Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details: Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international) Conference ID: 6663619 Webcast: Available in the \u201cInvestors\u201d section of the Ocugen website and archived for approximately 45 days following the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-520746","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., July 30, 2021 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its second quarter 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, August 6, 2021. Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details: Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international) Conference ID: 6663619 Webcast: Available in the \u201cInvestors\u201d section of the Ocugen website and archived for approximately 45 days following the &hellip; Continue reading &quot;Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-30T12:48:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update\",\"datePublished\":\"2021-07-30T12:48:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/\"},\"wordCount\":480,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/\",\"name\":\"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=\",\"datePublished\":\"2021-07-30T12:48:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/","og_locale":"en_US","og_type":"article","og_title":"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update - Market Newsdesk","og_description":"MALVERN, Pa., July 30, 2021 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its second quarter 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, August 6, 2021. Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details: Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international) Conference ID: 6663619 Webcast: Available in the \u201cInvestors\u201d section of the Ocugen website and archived for approximately 45 days following the &hellip; Continue reading \"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-30T12:48:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update","datePublished":"2021-07-30T12:48:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/"},"wordCount":480,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/","name":"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=","datePublished":"2021-07-30T12:48:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDA3NyM0MzIzMDEzIzIxODQ1MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-host-conference-call-on-friday-august-6-at-830-a-m-et-to-discuss-second-quarter-2021-financial-results-and-provide-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=520746"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520746\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=520746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=520746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=520746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}